Pierre Fabre and Cordeliers Research Centre Enter into strategic partnership to identify new therapeutic targets in immuno-oncology

Castres, France, December 14, 2015 – Pierre Fabre Médicament (PFM) announces a strategic partnership with Inserm and its academic partners (Université Paris Descartes-Paris V, Université Pierre et Mar... Read more

NAREB: a EU-funded research project for combating antibiotic resistance

18th November 2015: European Antibiotic Awareness Day [1] The World Health Organization has declared antibiotic resistance as one of the three greatest threats to human health [2]. This has promoted Read more

Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers

MADISON, N.J. USA, PARIS, France, BURLINGTON, N.C. USA -- April 21, 2015 – Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, and Inserm, the French Nation... Read more

Creation of HalioDx

Marseille, France, March 23, 2015 – HalioDx, created from a management buy-out of QIAGEN Marseille, today announces its inception. HalioDx ambition is to become the reference company in immuno-oncolog... Read more

European Patent Office rankings for 2014: Inserm 6th in France for patent applications, 1st in Europe for academic patent applications in biomedical research

Inserm, with the help of its subsidiary Inserm Transfert, continues to rise in the 2014 rankings of French patent applicants issued by the European Patent Office (EPO). Inserm is placed 6th in France ... Read more

Advanced Biological Laboratories Enters into Worldwide Exclusive License Agreement for HIV Tropism Determination Technology with Inserm and Inserm Transfert SA, and the Centre Hospitalier Universitaire de Toulouse

LUXEMBOURG VILLE, Luxembourg, Jan. 26, 2015 /PRNewswireiReach/ -- Advanced Biological Laboratories (ABL) S.A., today announced the signing of an exclusive worldwide license for commercial use of the P... Read more

Huntington's disease: therapeutic potential of triheptanoin confirmed

A team of researchers from Inserm led by Fanny Mochel and located at the  Brain and spinal Cord Institute.... Download Press Release... Read more

Christos Chatziantoniou at Inserm UMR 1155 Wins GSK’s Discovery Fast Track Challenge to Investigate Chronic Kidney Disease

Paris, France - 1 December, 2014 - Christos Chatziantoniou, Director of Research at the Inserm UMR 1155, has been selected as a winner of GSK’s 2014 Discovery Fast Track Challenge, which is desig... Read more

Inserm Transfert (France) and Translational Research Informatics Center (Japan) enter into international cooperation agreement regarding translational researches

Paris, (France), Kobe (Japan), May 7, 2014 - Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), and Translational Research Informati... Read more

Cécile Tharaud appointed as President and Managing Partner of Inserm Transfert Initiative

The Supervisory Board of Inserm Transfert Initiative – which is composed of Bpifrance1 , Inserm Transfert, AbbVie, Boehringer Ingelheim Venture Fund, MSD, GlaxoSmithKline, Ipsen, Pfizer, MSD (Merck &a... Read more

Results 1 - 10 of 29